InvestorsHub Logo
Followers 16
Posts 4516
Boards Moderated 4
Alias Born 12/06/2018

Re: rodman post# 13097

Tuesday, 03/05/2024 12:18:48 PM

Tuesday, March 05, 2024 12:18:48 PM

Post# of 13839
It works so damn well...it failed Class II...

"On 12/4/17, UEEC issued a PR stating:
it is proceeding with its application for HemoStyp under the FDA’s new and innovative CtQ Pilot Program. The FDA selected UHP’s HemoStyp as only one of nine participants for the program.
Concurrent with its CtQ Pilot Program participation, UHP reaffirms that its current Class II application – Expanded Indication submission with the US FDA-- continues to progress, and is in an advanced stage of review"


https://seekingalpha.com/article/4300303-united-health-products-press-releases-cannot-be-taken-face-valuee
and no one will buy this POS bandage over the counter either...
https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf
Bearish
Bearish